Walking, Education Intervention Prevents Recurrence of Low Back Pain

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 28, 2024 -- An individualized, progressive walking and education intervention is beneficial for prevention of recurrence of low back pain, according to a study published online June 19 in The Lancet.

Natasha C. Pocovi, Ph.D., from Macquarie University in Sydney, and colleagues examined the clinical effectiveness and cost-effectiveness of an individualized, progressive walking and education intervention to prevent the recurrence of low back pain in a randomized trial involving adults across Australia who had recently recovered from an episode of nonspecific low back pain. Participants were randomly assigned to an individualized intervention facilitated by six sessions with a physical therapist over six months (351 participants) or to a no-treatment control group (350 participants) and were followed for a minimum of 12 months.

The researchers found that the intervention was effective for preventing an episode of activity-limiting low back pain (hazard ratio, 0.72). The median days to a recurrence was 208 and 112 days in the intervention and control groups, respectively. The incremental cost per quality-adjusted life year gained was $7,802 (Australian dollars); at a willingness-to-pay threshold of $28,000, there was a 94 percent probability that the intervention was cost-effective. The total number of participants experiencing at least one adverse event over 12 months was similar in the intervention and control groups (52 and 54 percent, respectively), but more adverse events relating to the lower extremities were seen in the intervention group (100 versus 54 events).

"By encouraging active self-management using health coaching principles, the WalkBack intervention might be able to reduce the prevalence of recurrent low back pain and associated burden on health care systems," the authors write.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-29 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords